curasan AG (CUR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:curasan AG (CUR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7069
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, oral and maxillofacial surgeons, and periodontists and dental implantologists in the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company has a research and development, and manufacturing facility in Frankfurt, Germany. The company offers its products through a network of distributors in the Americas, Europe, the Middle East and Asia. curasan is headquartered in Kleinostheim, Germany.

curasan AG (CUR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
curasan AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
curasan AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
curasan AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
curasan AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
curasan AG, Medical Equipment, Deal Details 10
Partnerships 10
Xtant Medical Enters into Distribution Agreement with Curasan 10
curasan Enters into Licensing Agreement with Silony Medical 11
Equity Offering 12
Curasan Raises USD2.7 Million in Second Tranche of Rights offering of Shares 12
Curasan to Raise USD6 Million in Private Placement of Shares 13
Curasan to Raise Funds through Private Placement of Shares 14
Curasan Raises USD1.2 Million in Private Placement of Shares 15
curasan to Raise USD4.6 Million in Rights Issue of Shares 16
curasan AG – Key Competitors 17
curasan AG – Key Employees 18
curasan AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
May 24, 2018: curasan concludes first quarter in line with annual guidance 20
Apr 26, 2018: Curasan Reports Full Year 2017 Financial Results 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
curasan AG, Medical Equipment, Key Facts, 2017 2
curasan AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
curasan AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
curasan AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
curasan AG, Deals By Market, 2012 to YTD 2018 8
curasan AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Xtant Medical Enters into Distribution Agreement with Curasan 10
curasan Enters into Licensing Agreement with Silony Medical 11
Curasan Raises USD2.7 Million in Second Tranche of Rights offering of Shares 12
Curasan to Raise USD6 Million in Private Placement of Shares 13
Curasan to Raise Funds through Private Placement of Shares 14
Curasan Raises USD1.2 Million in Private Placement of Shares 15
curasan to Raise USD4.6 Million in Rights Issue of Shares 16
curasan AG, Key Competitors 17
curasan AG, Key Employees 18
curasan AG, Subsidiaries 19

List of Figures
curasan AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
curasan AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
curasan AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[curasan AG (CUR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verizon Communications Inc.:企業の戦略・SWOT・財務情報
    Verizon Communications Inc. - Strategy, SWOT and Corporate Finance Report Summary Verizon Communications Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Milestone Scientific Inc (MLSS):製品パイプライン分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments. The company provides medical products and dental products. Its medical products include epidurals, intra-articular injections, …
  • AZTherapies Inc-製薬・医療分野:企業M&A・提携分析
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company, which focuses on the discovery, development and commercialization of medicines for the treatment of Alzheimer’s disease and other neuroinflammatory and neurodegenerative diseases. Its product pipeline includes the le …
  • Samuel Heath & Sons Plc:企業の戦略・SWOT・財務情報
    Samuel Heath & Sons Plc - Strategy, SWOT and Corporate Finance Report Summary Samuel Heath & Sons Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Health Net, LLC.:企業の戦略・SWOT・財務分析
    Health Net, LLC. - Strategy, SWOT and Corporate Finance Report Summary Health Net, LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Acino International AG:企業の戦略的SWOT分析
    Acino International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Topdanmark AS (TOP):企業の財務・戦略的SWOT分析
    Topdanmark AS (TOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nordkraft AS:電力:M&Aディール及び事業提携情報
    Summary Nordkraft AS (Nordkraft) is an alternative energy company that offers renewable energy and related solutions. The company produces power and energy from magazine power, small hydro, and wind power, among others. It owns and operates power and energy generation plants magazine in the area of …
  • Exalenz Bioscience Ltd:企業の戦略的SWOT分析
    Exalenz Bioscience Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Fenwal Inc-医療機器分野:企業M&A・提携分析
    Summary Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512):企業の財務・戦略的SWOT分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is a manufacturer of medical devices. The company develops, manufactures and distributes pharmaceutical preparations, medical devices pharmaceutical intermediates, specialized raw materials, and healthcare products. It also …
  • Sinochem Group:企業の戦略・SWOT・財務分析
    Sinochem Group - Strategy, SWOT and Corporate Finance Report Summary Sinochem Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Granules India Ltd (GRANULES):製薬・医療:M&Aディール及び事業提携情報
    Summary Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, …
  • Aerie Pharmaceuticals Inc (AERI):製薬・医療:M&Aディール及び事業提携情報
    Summary Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates comprise rhopressa, a once-daily eye drop which is used for the redu …
  • Bank of China Ltd:戦略・SWOT・企業財務分析
    Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sound Energy plc (SOU):企業の財務・戦略的SWOT分析
    Summary Sound Energy Plc (Sound Energy), formerly Sound Oil plc is an upstream oil and gas company that offers exploration and development of oil and gas properties in Europe and Africa. The company holds interests, owns, and operates the Badile permit located in the Piedmont Lombard Basin in northe …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology engaged in the development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products which include MGN1601, and others. It also engaged in developing EnanDIM product to treat antitumor efficacy by stimulatin …
  • Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Mercuria Energy Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Mercuria Energy Group Ltd (Mercuria Energy) is an independent energy and commodity company that carries out sourcing, supplying and trading of crude oil and refined petroleum products through its subsidiaries. Its portfolio includes petrochemicals, biofuels, environmental products, natural g …
  • InvitroCue Ltd (IVQ):企業の財務・戦略的SWOT分析
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd, is a provider of bio-analytic solutions. The company provides digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆